Literature DB >> 20217364

Cardiorespiratory alterations induced by intermittent hypoxia in a rat model of sleep apnea.

Rodrigo Iturriaga1, Esteban A Moya, Rodrigo Del Rio.   

Abstract

The obstructive sleep apnea (OSA) syndrome, characterized by repeated episodes of intermittent hypoxia is recognized as an independent risk factor for hypertension. One potential contributing mechanism to the OSA-induced hypertension is the potentiation of the carotid body chemosensory responses to hypoxia, which is responsible for the augmented sympathetic modulation of heart rate variability (HRV) and the enhanced ventilatory response to hypoxia found in OSA patients and animal exposed to chronic intermittent hypoxia (CIH). However, it is not known if the cardiorespiratory alterations may precede the hypertension. Thus, we studied the effects of CIH on arterial pressure, HRV and ventilatory response to acute hypoxia in rats exposed to CIH (5% O(2), 12 times/h per 8 h) or sham condition for 7-21 days. Exposure of rats to CIH for 14 days enhanced the ventilatory response to hypoxia and produced a significant shift of the HRV power spectrum, with a predominance of the sympathetic modulation. These cardiorespiratory alterations occurred without noticeable changes in arterial blood pressure, until 21 days of CIH exposure. Thus, our results support the idea that the hypertension induced by CIH was preceded by alterations in the autonomic balance of HRV, associated with an enhance chemoreflex ventilatory reactivity in normotensive animals.

Entities:  

Mesh:

Year:  2010        PMID: 20217364     DOI: 10.1007/978-1-4419-5692-7_55

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  13 in total

1.  Increased cardio-respiratory coupling evoked by slow deep breathing can persist in normal humans.

Authors:  Thomas E Dick; Joseph R Mims; Yee-Hsee Hsieh; Kendall F Morris; Erica A Wehrwein
Journal:  Respir Physiol Neurobiol       Date:  2014-09-28       Impact factor: 1.931

Review 2.  Apneic Sleep, Insufficient Sleep, and Hypertension.

Authors:  Meghna P Mansukhani; Naima Covassin; Virend K Somers
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

Review 3.  Sleep, death, and the heart.

Authors:  Meghna P Mansukhani; Shihan Wang; Virend K Somers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-17       Impact factor: 4.733

4.  Can short-term heart rate variability be used to monitor fentanyl-midazolam induced changes in ANS preceding respiratory depression?

Authors:  Anne-Louise Smith; Harry Owen; Karen J Reynolds
Journal:  J Clin Monit Comput       Date:  2014-09-20       Impact factor: 2.502

Review 5.  Cardiovascular consequences of sleep apnea.

Authors:  Saeid Golbidi; Mohammad Badran; Najib Ayas; Ismail Laher
Journal:  Lung       Date:  2011-11-03       Impact factor: 2.584

Review 6.  Chemoreflexes, sleep apnea, and sympathetic dysregulation.

Authors:  Meghna P Mansukhani; Tomas Kara; Sean M Caples; Virend K Somers
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

Review 7.  The efficacy of antihypertensive drugs in chronic intermittent hypoxia conditions.

Authors:  Lucilia N Diogo; Emília C Monteiro
Journal:  Front Physiol       Date:  2014-09-22       Impact factor: 4.566

8.  Influence of chronic intermittent hypoxia on growth associated protein 43 expression in the hippocampus of young rats.

Authors:  Yan Chen; Chunling Zhao; Chunlai Zhang; Lirong Luo; Guang Yu
Journal:  Neural Regen Res       Date:  2012-06-05       Impact factor: 5.135

Review 9.  Chemoreflex physiology and implications for sleep apnoea: insights from studies in humans.

Authors:  Meghna P Mansukhani; Shihan Wang; Virend K Somers
Journal:  Exp Physiol       Date:  2014-12-08       Impact factor: 2.969

10.  Chronic Intermittent Hypoxia-Induced Vascular Dysfunction in Rats is Reverted by N-Acetylcysteine Supplementation and Arginase Inhibition.

Authors:  Bernardo J Krause; Paola Casanello; Ana C Dias; Paulina Arias; Victoria Velarde; German A Arenas; Marcelo D Preite; Rodrigo Iturriaga
Journal:  Front Physiol       Date:  2018-07-24       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.